Recruiting
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
NCT06650332
- Conditions
- Metastatic HER2 Positive Gastroesophageal Junction Cancer
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China